MICROPORT CARDIO.MEDTECH. (72X) — Defensive Interval Ratio

Latest as of June 2025: 1800 days

MICROPORT CARDIO.MEDTECH. (72X) has a Defensive Interval Ratio of 1800 days as of June 2025. Defensive assets of €1.21 Billion (cash €-, short-term investments €987.89 Million, receivables €222.96 Million) cover 1800 days of daily cash needs of €672.70K/day. Check MICROPORT CARDIO.MEDTECH. tangible book value ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

1800 days
Days of operational coverage

Defensive Assets

€1.21 Billion
Cash + ST Investments + Receivables

Daily Cash Need

€672.70K
Current Liabilities ÷ 365

Current Liabilities

€245.53 Million
EUR

MICROPORT CARDIO.MEDTECH. Defensive Interval Ratio (2021–2024)

This chart shows how MICROPORT CARDIO.MEDTECH.'s Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of June 2025, the ratio stands at 1800 days, meaning defensive assets of €1.21 Billion can fund 1800 days of operations without new revenue. Also explore MICROPORT CARDIO.MEDTECH. (72X) net asset momentum to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for MICROPORT CARDIO.MEDTECH. (2021–2024)

The table below presents the year-by-year Defensive Interval Ratio for MICROPORT CARDIO.MEDTECH. from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see MICROPORT CARDIO.MEDTECH. stock valuation.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2024 1167 days €1.39 Billion €1.19 Million/day €- €1.25 Billion ▼ -359 days
2023 1526 days €809.27 Million €530.36K/day €- €708.27 Million ▲ +993 days
2022 533 days €258.71 Million €485.56K/day €- €208.94 Million ▲ +367 days
2021 166 days €74.71 Million €450.50K/day €- €-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)